Skip to content

Vitamin D Supplementation and Regulatory FoxP3+ T Cells in the GUT

Pilot Study to Assess the Effects of Vitamin D Supplementation on the Number of Regulatory FoxP3+ T Cells in the Gastrointestinal Mucosa in Healthy Women and Men: Step 3 in the Austrian Diabetes Prevention Programme

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01538485
Enrollment
16
Registered
2012-02-24
Start date
2012-01-31
Completion date
2012-08-31
Last updated
2012-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune Tolerance

Keywords

Vitamin D, regulatory T cells, GUT

Brief summary

In this pilot study the investigators aim to investigate the effects of vitamin D supplementation on regulatory FoxP3+ T cells in the gastrointestinal mucosa in healthy women and men.

Detailed description

This is a monocentric, open pilot study, with the aim to evaluate the effect of vitamin d supplementation on regulatory FoxP3+ T cells in the gastrointestinal mucosa in healthy women and men. The primary goal is to evaluate the influence of vitamin D supplementation on the regulatory FoxP3+ T cells in the gastrointestinal mucosa under controlled conditions within 2 months. The secondary study goals are to evaluate the effect of vitamin D supplementation on peripheral induced tregs and on other important immune cells in the tissue (NK, NKT cells and LPCD) and in the blood (NK, NKT cells, Th17, Th1, Th2 cells) within 2 months.

Interventions

DRUGCholecalciferol

weekly dose (based on 70IU KG body weight/day)

Sponsors

Medical University of Graz
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-40 years * non smoker * BMI: 20-30 kg/m² * Healthy

Exclusion criteria

* hypercalcemia \> 2,65 mmol/L * pregnancy * chronic diseases

Design outcomes

Primary

MeasureTime frameDescription
Increase of regulatory FOXP3+ T cells2 monthsthe effects of vitamin D on regulatory FOXP3+ T cells will be measured at basal and after 2 months

Secondary

MeasureTime frame
other immune cells in the gastrointestinal mucosa2 months
serum calcium level2 months

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026